MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/eci.70055

Медицинская библиотека · European journal of clinical investigation · 2025

Bosutinib mitigates inflammation in experimental sepsis.

Cunha C M C, Abreu V H P, Estato V, Soares G M V, Moraes B P T, Oliveira G P, Silva J D, Silva P L, Immler R, Rocco P R, Sperandio M, Silva A R, Bozza P T, Castro-Faria-Neto H C, Gonçalves-de-Albuquerque C F

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Sepsis, a leading cause of death globally, lacks targeted and effective treatment. Its pathophysiology involves unbalanced inflammation, marked by a high release of inflammatory mediators, leukocyte recruitment, vascular changes and dysfunction of the nervous and respiratory systems. Src family tyrosine kinases (SFK) play a critical role in immune responses, and their inhibition can modulate excessive inflammation. This study investigates the potential of bosutinib, an SFK inhibitor, as a treatment for sepsis.

METHODS

Clinical signs, survival rates, systemic and neuronal inflammatory responses, cell recruitment, lung function and cerebral microcirculation were analysed in mice treated with bosutinib (3 mg/kg) or DMSO/saline followed by cecal ligation and puncture (CLP)-induced sepsis.

RESULTS

Bosutinib treatment reduced the severity of sepsis, improved survival rates and reduced the levels of pro-inflammatory cytokines and chemokines in peritoneal lavage, plasma and brain tissue. It also reduced cellular infiltration and bacterial growth at the infection site and protected lung function by reducing diffuse alveolar damage. Using intravital microscopy and laser speckle techniques, bosutinib improved capillary density and blood perfusion and reduced leukocyte recruitment and adhesion in the cerebral microcirculation of septic animals.

CONCLUSIONS

Bosutinib pretreatment attenuated dysregulated inflammatory responses and neurovascular changes in experimental sepsis.

Для цитирования: Cunha C M C, Abreu V H P, Estato V, Soares G M V, Moraes B P T, Oliveira G P, Silva J D, Silva P L, Immler R, Rocco P R, Sperandio M, Silva A R, Bozza P T, Castro-Faria-Neto H C, Gonçalves-de-Albuquerque C F. Bosutinib mitigates inflammation in experimental sepsis.. European journal of clinical investigation. 2025. DOI: 10.1111/eci.70055.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.